NASDAQ:CPRX - Catalyst Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$5.31 +0.05 (+0.95 %)
(As of 04/19/2019 01:15 PM ET)
Previous Close$5.26
Today's Range$5.10 - $5.34
52-Week Range$1.85 - $5.68
Volume936,834 shs
Average Volume1.55 million shs
Market Capitalization$545.54 million
P/E RatioN/A
Dividend YieldN/A
Beta2.43

SEC Filings

Catalyst Pharmaceuticals (NASDAQ:CPRX) SEC Filings

DateFilerForm TypeView
04/18/2019
4:15 PM
Catalyst Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/18/2019
3:37 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/18/2019
3:08 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/06/2019
8:18 AM
Catalyst Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
View Filing
02/27/2019
10:29 AM
Catalyst Pharmaceuticals (Filer)
Form CT ORDER
View Filing
02/14/2019
10:15 AM
Catalyst Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G
View Filing
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/13/2019
3:26 PM
Broadfin Capital, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
01/04/2019
3:45 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/28/2018
11:29 AM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/26/2018
4:01 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/21/2018
3:48 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:48 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:47 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:47 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:47 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:46 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:46 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:46 PM
BRENNAN DANIEL (Reporting)
Catalyst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:46 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:45 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/19/2018
3:25 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/18/2018
3:49 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/17/2018
3:19 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:50 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/29/2018
7:29 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/07/2018
3:41 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/07/2018
3:08 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
09/28/2018
11:23 AM
Catalyst Pharmaceuticals (Filer)
Form CT ORDER
View Filing
08/17/2018
4:15 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/07/2018
4:16 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/15/2018
4:00 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/15/2018
4:00 PM
BRENNAN DANIEL (Reporting)
Catalyst Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/11/2018
7:48 AM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:26 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2018
2:35 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/31/2018
4:00 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/31/2018
10:57 AM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
7:20 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/25/2018
4:25 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
3:41 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
3:06 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/19/2018
7:30 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/17/2018
4:16 PM
Catalyst Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/03/2018
3:13 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/29/2018
7:37 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
3:27 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
3:05 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
3:50 PM
Catalyst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2018
3:31 PM
Broadfin Capital, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/13/2018
3:09 PM
BAKER BROS. ADVISORS LP (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/12/2018
7:24 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/08/2018
9:42 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/04/2018
3:58 PM
Catalyst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2018
3:50 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2018
3:48 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2018
3:47 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2018
3:46 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/08/2017
3:00 PM
Catalyst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G
View Filing
11/30/2017
3:49 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/28/2017
4:18 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 4/19/2019 by MarketBeat.com Staff

Featured Article: Trading Strategy

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel